Application of protein - protein interaction as an assay for...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

195/33

G01N 33/60 (2006.01) C12N 9/00 (2006.01) C12Q 1/25 (2006.01)

Patent

CA 1094476

ABSTRACT OF THE DISCLOSURE A specific type of protein, which has been designated B-protein (Bucovaz-protein), is present in most serum of indivi- duals with cancer. The B-protein interacts with a low molecular weight protein component, which is released by the coenzyme A- synthesizing protein complex (Coa-SPC) of Bakers' yeast during the course of CoA synthesis. This low molecular weight protein, for purposes of identification, is referred to as binding protein. The binding protein has a molecular weight of 10,000 to 15,000. Interaction of radioactively labeled binding protein of CoA-SPC with the B-protein of serum provides a marker for the detection of cancer. Of 3005 serums assayed, which included 908 patients diagnosed as having cancer, the B-protein assay agreed with the clinical diagnosis in more than 89% of the cases.

276356

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Application of protein - protein interaction as an assay for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Application of protein - protein interaction as an assay for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Application of protein - protein interaction as an assay for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-258359

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.